![](/img/cover-not-exists.png)
A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer
Steven J. Cohen, Mark M. Zalupski, Manuel R. Modiano, Paul Conkling, Yehuda Z. Patt, Peg Davis, Robert T. Dorr, Michelle L. Boytim, Evan M. HershVolume:
66
Language:
english
Pages:
8
DOI:
10.1007/s00280-009-1162-y
Date:
July, 2010
File:
PDF, 275 KB
english, 2010